Back
Pioneer Natural Resources Vs. Akero Therapeutics Industry Stock Comparison
Buy
54
PXD
Pioneer Natural Resources
Last Price:
262.73
Seasonality Move:
10.63%
Sell
48
AKRO
Akero Therapeutics
Last Price:
25.24
Seasonality Move:
12.31%
Buy
54
Pioneer Natural Resources (PXD)
is a Buy
Is Pioneer Natural Resources a Buy, Sell or Hold?
- The current Pioneer Natural Resources [PXD] share price is $260.00. The Score for PXD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- PXD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $24.48. The Score for AKRO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PXD Stock Price Chart
What is Pioneer Natural Resources's stock price today?
-
The Pioneer Natural Resources share price today is $260.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PXD is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $24.48
The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
PXD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.69 | Buy |
Relative Strength Index (14 RSI): | 78.53 | Buy |
Chaikin Money Flow: | 808674 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (235.75 - 253.75) | Buy |
Bollinger Bands (100): | (223.14 - 242.68) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 43.35 | Sell |
Chaikin Money Flow: | 171453 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.88 - 29.44) | Sell |
Bollinger Bands (100): | (17.36 - 26.04) | Buy |
PXD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 255.79 | Buy |
20-day SMA: | 247.49 | Buy |
50-day SMA: | 235.71 | Buy |
200-day SMA: | 229.92 | Buy |
8-day EMA: | 255.42 | Buy |
20-day EMA: | 248.85 | Buy |
50-day EMA: | 240.24 | Buy |
200-day EMA: | 231.33 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.24 | Sell |
20-day SMA: | 27.54 | Sell |
50-day SMA: | 24.21 | Buy |
200-day SMA: | 31.66 | Sell |
8-day EMA: | 25.32 | Sell |
20-day EMA: | 26 | Sell |
50-day EMA: | 24.96 | Sell |
200-day EMA: | 28.74 | Sell |
Pioneer Natural Resources Earnings Growth & PXD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.80 per share, and an increase next year of $1.47 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.
Pioneer Natural Resources Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |